Abstract
Erectile dysfunction (ED), the consistent inability of a man to achieve an erection satisfactory for sexual activity, has been estimated to afflict, to some degree, 52% of male adults between the ages of 40 and 70 yr in the United States (1).Millions of men in the United States suffer with ED. Although there are numerous causes of ED (vascular, psychogenic, neurologic, endocrine, structural, traumatic, and drug-related) in men over age 50 yr, the most common cause is thought to be vascular (2–4). This chapter reviews the connection between ED and vascular disease and the connection between ED and risk factors for atherosclerosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Morley JE, Kaiser FE. Impotence in elderly men. Drugs Aging 1992; 2: 330–344.
Sullivan ME, Keoghane SR, Miller MAW. Vascular risk factors and erectile dysfunction. BJU Int 2001; 87: 838–845.
Bortolotti A, Parazzini F, Colli E, et al. The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.
Jarow J, Kloner RA, Holmes AM. Viagra M. Evans and Company, Inc. New York, 1998, pp. 1–150.
Burnett AL. Nitric oxide in the penis: physiology and pathology. J Urol 1997; 157: 320–324.
Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 8422: 181–184.
Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prey Med 2000; 30: 328–338.
Bulpitt CJ, Dollery CT, Carne S. Change in symptom of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121–128.
Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.
Williams GH, Croog SH, Levine S, et al. Impact of antihypertensive therapy on quality of life: effect of hydrochlorothiazide. J Hypertens 1987; 5 (Suppl 1): S29 - S35.
Jensen J, Lendorf A, Stimpel H, et al. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999; 12: 271–275.
Grimm RH, Grandits GA, Priueas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women in the Treatment of Mild Hypertension Study. (THOMS) Hypertension 1997; 29: 8–14.
Wassertheil-Smoller S, Blaufox MD, Oberman A, et al., for the TAIM Research Group. Effects of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med 1991; 114: 613–620.
Fogari R, Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001; 14: 27–31.
Wei M, Macera CA, Davis DR, et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.
Rosen RC, Weiner DN. Cardiovascular disease and sleep-related erections. J Psychosom Res 1997; 42: 515–516.
Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002; 19: 95–98.
Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.
McVary KT, Carrier S, Wessells H, the Subcommittee on smoking and erectile dysfunction, Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence-based analysis. J Urol 2001; 166: 1624–1632.
Jeremy JY, Mikhallidis DP, Thompson CS, et al. The effect of cigarette smoke and diabetes mellitus on muscarinic stimulation of prostacyclin synthesis by the rat penis. Diabetes Res 1986; 3: 467–469.
Shabsigh R, Fishman IJ, Schum C, et al. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology 1991; 38: 227–231.
Rosen MP, Greenfield AJ, Walker TG, et al. Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 1991; 145: 759–763.
Mannino DM, Klevens RM, Flanders WD. Cigarette smoking: an independent risk factor for impotence? Am J Epidemiol 1994; 140: 1003–1008.
Ledda A. Cigarette smoking, hypertension and erectile dysfunction. Curr Med Res Opin 2000; 16 (Suppl 1): S13 - S16.
Juenemann K-P, Lue TF, Luo J-A, et al. The effect of cigarette smoking on penile erection. J Urol 1987; 138: 438–441.
Jacobs MC, Lenders JW, Kapma JA, et al. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans. Clin Sci 1993; 85: 51–55.
Levine LA, Gerber GS. Acute vasospasm of penile arteries in response to cigarette smoking. Urology 1990; 36: 99–100.
Mersdorf A, Goldsmith PC, Diederichs W, et al. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients. J Urol 1991; 145: 749–758.
Guay AT, Perez JB, Heatly GJ. Cessation of smoking rapidly decreases erectile dysfunction. Endocrine Pract 1998; 4: 23.
Klein R, Klein BEK, Lee ICE, et al. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135–141.
De-Tejada IS, Goldstein I, Azadzoi K, et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–1030.
Guay AT. Sexual dysfunction in the diabetic patients. Int J Impot Res 2001; 13 (Suppl 5): S47 - S50.
Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997; 9: 123–126.
Pritzker MR. The penile stress test: a window to the hearts of man? 72nd Scientific Sessions of the American Heart Association, November 7–10, 1999; Atlanta, Georgia. Abstract 104–561.
O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001; 55: 219–220.
Kirby M, Jackson G, Betteridge J, et al. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001; 155: 614–618.
Kloner RA, Mullin SH, Shook T, et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003; 170: S46–550.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Kloner, R.A. (2004). Erectile Dysfunction and Cardiovascular Risk Factors. In: Kloner, R.A. (eds) Heart Disease and Erectile Dysfunction. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-748-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-748-2_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9849-3
Online ISBN: 978-1-59259-748-2
eBook Packages: Springer Book Archive